Jordan Green, FNP
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $539.07 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $183.25 | 12 | $0 (2023) |
| Amgen Inc. | $133.65 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $68.38 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.06 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $28.24 | 1 | $0 (2023) |
| Lilly USA, LLC | $27.18 | 1 | $0 (2023) |
| Novo Nordisk Inc | $17.59 | 1 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $14.88 | 1 | $0 (2023) |
| Averitas Pharma Inc. | $12.84 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $539.07 | 24 | ABBVIE INC. ($183.25) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Inflammation | ||||||
| 08/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: INSOMNIA | ||||||
| 05/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $53.06 | General |
| Category: DIABETES | ||||||
| 04/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $98.62 | General |
| Category: Cardiology | ||||||
| 03/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 60 | $11,844 | $3,240 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 48 | $8,640 | $2,300 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 12 | $3,204 | $940.34 | 29.3% |
About Jordan Green, FNP
Jordan Green, FNP is a Student in an Organized Health Care Education/Training Program healthcare provider based in Vidor, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2022. The National Provider Identifier (NPI) number assigned to this provider is 1538893383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jordan Green, FNP has received a total of $539.07 in payments from pharmaceutical and medical device companies, with $539.07 received in 2023. These payments were reported across 24 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($539.07).
As a Medicare-enrolled provider, Green has provided services to 47 Medicare beneficiaries, totaling 60 services with total Medicare billing of $3,240. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family
- Location Vidor, TX
- Active Since 07/15/2022
- Last Updated 03/10/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538893383
Products in Payments
- VRAYLAR (Drug) $132.15
- Repatha (Biological) $98.62
- TRINTELLIX (Drug) $68.38
- JARDIANCE (Drug) $53.06
- QULIPTA (Drug) $51.10
- Otezla (Drug) $35.03
- AREXVY (Drug) $28.24
- MOUNJARO (Drug) $27.18
- Ozempic (Drug) $17.59
- QUVIVIQ (Drug) $14.88
- QUTENZA (Drug) $12.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.